Opioid Antidote (Naloxone) to be Available Over-The-Counter in B.C. and Alberta

Overview

Food and Drug Law
Food and Drug Regulatory LawOn March 22, Health Canada amended the listing for Naloxone on the Prescription Drug List, granting an exception to the prescription-required status of Naloxone where the drug is for emergency use for opioid overdose outside of hospitals. Shortly afterwards, the B.C. Drug Schedules Regulation was amended to classify non-prescription Naloxone as a Schedule II drug, allowing over-the-counter sales.

Similarly, Alberta Health announced that pharmacies would be authorized to provide take-home naloxone kits free-of-charge, and would be introducing regulatory amendments to allow Naloxone to be sold without a prescription.

Follow our FDL updates us on Twitter: @TorysFDL
MailClick here to subscribe to Torys' insights and updates.

Lawyers